An interview with Cyrille Pauthenier, Chief Executive Officer of Abolis Biotechnologies, where we discuss the benefits of biosynthesis, the challenges facing the pharmaceutical, cosmetics, chemical and food sectors, the importance of brainstorming and lessons learnt to help biotech startups.
Please note: Bio Market Insights is owned and operated by TNP Media Ltd, after being acquired from Quantuma in April 2021.